Health Care & Life Sciences » Biotechnology | Oxford Immunotec Global PLC

Oxford Immunotec Global PLC

Oxford Immunotec Global PLC
Stock Exchange NASDAQ Stock Market
EPS
$0.61
Market Cap
$368.46 M
Shares Outstanding
26.62 M
Public Float
23.89 M

Profile

Address
Milton Park
Abingdon Oxfordshire OX14 4RZ
United Kingdom
Employees -
Website http://oxfordimmunotec.com
Updated 07/08/2019
Oxford Immunotec Global Plc operates as a medical diagnostics company, which develops and commercializes proprietary tests for under-served immune-regulated conditions. Its current product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology. Its products include T-SPOT.

Financials

View All
Created with Highcharts 5.0.14Oxford Immunotec Global PLCNet Income. Fiscal year is January-December. All values USD Thousands.8 6648 66422 17422 17424 47824 47822 34922 34932 88532 88512 50512 505201320142015201620172018010k20k30k40k
Created with Highcharts 5.0.14Oxford Immunotec Global PLCSales/Revenue. Fiscal year is January-December. All values USD Thousands.38 78438 78449 50549 50562 78262 78286 07886 078103 080103 08059 75359 753201320142015201620172018025k50k75k100k125k

Peter James Wrighton-Smith
Chief Executive Officer & Executive Director
Patricia Randall
Non-Executive Director